These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6545273)

  • 21. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.
    Calleman CJ; Ehrenberg L; Jansson B; Osterman-Golkar S; Segerbäck D; Svensson K; Wachtmeister CA
    J Environ Pathol Toxicol; 1978; 2(2):427-42. PubMed ID: 739221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
    Dugue B; Auclair C; Meunier B
    Cancer Res; 1986 Aug; 46(8):3828-33. PubMed ID: 2425935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for unknown adducts: increase of sensitivity through preselection by biochemical parameters.
    Törnqvist M
    IARC Sci Publ; 1988; (89):378-83. PubMed ID: 3198224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to the quantitation of alkylated amino acids in haemoglobin by gas chromatography mass spectrometry.
    Farmer PB; Bailey E; Lamb JH; Connors TA
    Biomed Mass Spectrom; 1980 Jan; 7(1):41-6. PubMed ID: 7397319
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular dosimetry techniques in human risk assessment: an industrial perspective.
    Wright AS
    Dev Toxicol Environ Sci; 1983; 11():311-8. PubMed ID: 6329628
    [No Abstract]   [Full Text] [Related]  

  • 26. [Genotoxic modification of nucleic acid bases and biological consequences of it. Review and prospects of experimental and computational investigations].
    Poltev VI; Bruskov VI; Shuliupina NV; Rein R; Shibata M; Ornstein R; Miller J
    Mol Biol (Mosk); 1993; 27(4):734-57. PubMed ID: 8361483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degree of alkylation of macromolecules in vivo from variable exposure.
    Granath F; Ehrenberg L; Törnqvist M
    Mutat Res; 1992 Dec; 284(2):297-306. PubMed ID: 1281281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The determination of in vivo alkylation of haemoglobin and DNA using gas chromatography-mass spectrometry.
    Farmer PB; Bailey E; Shuker DE
    Dev Toxicol Environ Sci; 1983; 11():273-80. PubMed ID: 6677462
    [No Abstract]   [Full Text] [Related]  

  • 30. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of cysteine in hemoglobin following exposure to methylating agents.
    Bailey E; Connors TA; Farmer PB; Gorf SM; Rickard J
    Cancer Res; 1981 Jun; 41(6):2514-7. PubMed ID: 7237445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotoxicity of epoxides and epoxy compounds.
    Hemminki K; Vainio H
    Prog Clin Biol Res; 1984; 141():373-84. PubMed ID: 6718385
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
    García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
    Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of intercalating drugs with nucleic acids.
    Berman HM; Young PR
    Annu Rev Biophys Bioeng; 1981; 10():87-114. PubMed ID: 7020585
    [No Abstract]   [Full Text] [Related]  

  • 35. Top-down characterization of nucleic acids modified by structural probes using high-resolution tandem mass spectrometry and automated data interpretation.
    Kellersberger KA; Yu E; Kruppa GH; Young MM; Fabris D
    Anal Chem; 2004 May; 76(9):2438-45. PubMed ID: 15117181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.
    De Flora S; Izzotti A; Randerath K; Randerath E; Bartsch H; Nair J; Balansky R; van Schooten F; Degan P; Fronza G; Walsh D; Lewtas J
    Mutat Res; 1996 Dec; 366(3):197-238. PubMed ID: 9033668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity.
    van der Woude H; Alink GM; van Rossum BE; Walle K; van Steeg H; Walle T; Rietjens IM
    Chem Res Toxicol; 2005 Dec; 18(12):1907-16. PubMed ID: 16359181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrofluorimetric techniques in the study of the interaction between fluorescent dyes and proteins or nuclear acids.
    Zaharia CN; Tărăbăşanu-Mihăilă C
    Virologie; 1978; 29(4):283-91. PubMed ID: 749334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of MS in structure elucidation of protein-nucleic acid complexes.
    Gordiyenko Y; Robinson CV
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):723-31. PubMed ID: 18631148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.